Telomerase and telomere inhibitors in preclinical development

Bibliography

• HOLT SE, SHAY JW, WRIGHT WE: Refining the telomere- ?telomerase hypothesis of aging and cancer. Nature Biotechnol. (1996) 15:1734–1741.
   Google Scholar
• A review of basic telomerase biology, and its relevance to ageing and cancer.
   Google Scholar
• KIM NW, PIATYSZEK MA, PROWSE KR et al.: Specific association of human telomerase activity with immor-tal cells and cancer. Science (1994) 266:2011–2015.
   PubMed Web of Science ®Google Scholar
• The first report describing the easy-to-use PCR-based assay that demonstrated the presence of telomerase activity in germ cells and tumours.
   Google Scholar
• RAYMOND E, SUN D, CHEN S-F, WINDLE B, VON HOFF DD: Agents that target telomerase and telomeres. Curr.Opin. Biotech. (1996) 7:583–591.
   PubMed Web of Science ®Google Scholar
• A detailed report on preclinical development of telomerase and telomeres as targets for cancer therapeutics.
   Google Scholar
• COUNTER CM, AVILION AA, LEFEUVRE CE et al: Telomereshortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO (1992) 11:1921–1929.
   PubMed Web of Science ®Google Scholar
• COUNTER CM, HIRTE HW, BACCHETTI S, HARLEY CB: Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA (1994) 91:2900–2904.
   PubMed Web of Science ®Google Scholar
• HIYAMA E, HIYAMA K, YOKOYAMA T et al.: Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. (1995) 1:249–255.
   PubMed Web of Science ®Google Scholar
• FENG J, FUNK WD, WANG SS et al.: The RNA componentof human telomerase. Science (1995) 269:1236–1241.
   PubMed Web of Science ®Google Scholar
• SHARMA S, RAYMOND E, SODA H et al: A model fortelomerase inhibition in lymphomas. Proc. Int. Am. Soc. Chemother. (1997) 72:A21.
   Google Scholar
• BURGER AM, DOUBLE JA, NEWELL DR: Inhibition of telomerase activity by cisplatin in human testicular cancer cells. Eur. J. Cancer (1997) 33:638–644.
   PubMed Web of Science ®Google Scholar
• BURGER AM, BIBBY MC, DOUBLE JA: Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. Br. J. Cancer (1997) 75:516–522.
   PubMed Web of Science ®Google Scholar
• OLIVERO OA, GOMEZ DE, KASSIM A, WINDLE BE: Prefer-ential incorporation of 3'-azido-2',3'dideoxythymidine (AZT) into telomeric DNA of Chinese hamster ovary (CHO) cells [Abstract]. Proc. Ann. Meet. Am. Assoc. Cancer Res. (1994) 35:A2024.
   Google Scholar
• OLIVERO OA, GOMEZ DE, KASSIM A, WINDLE BE: Telomeric DNA of CHO cells target for AZT (3'-azido-2',3'-dideoxythymidine) incorporation through telom-erase [Abstract]. Proc. Ann. Meet. Am. Assoc. Cancer Res. (1995) 36:A3312.
   Google Scholar
• CHEN SF, MAINE IP, WINDLE B: Effect of 3'-azidothymid-ine triphosphate (AZTTP) and 3'-azidothymidine (AZT) on telomerase activity and telomere function [Abstract]. Proc. Ann. Meet. Am. Assoc. Cancer Res. (1995) 36:A3302.
   Google Scholar
• MAINE IP, WINDLE B, CHEN SF: In vitro investigations of processive and non-processive telomerase activities [Meeting abstract]. Proc. Ann. Meet. Am. Assoc. Cancer Res. (1995) 36:A3303.
   Google Scholar
• STRAHL C, BLACKBURN EH: Effects of reverse transcrip- tase inhibitors on telomere length and telomerase ac-tivity in two immortalized human cell lines. Mol. Biol. (1996) 16:53–65.
   Web of Science ®Google Scholar
• The first report on effects of reverse transcriptase inhibitors on telomerase.
   Google Scholar
• JOSHI SS, PALEN BN, MATA JE, IVERSEN PL: Growth inhibitory effects of telomere mimic-oligonucleotides on human leukemia/lymphoma cells in vitro [Abstract]. Proc. Ann. Meet. Am. Assoc. Cancer Res. (1995) 36:A2449.
   Google Scholar
• MATA JE, JOSHI SS, PALEN B et al.: A hexameric phos-phothioronate oligonucleotide telomerase inhibitor ar- rests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicol Appl. PharmacoL (1997) 144:18–197.
   Google Scholar
• IVERSEN PL, PIRRUCCELLO SJ, MATA JE, JOSHI SS: Antis-ense oligonucleotides which demonstrate tumour spe-cific action also inhibit telomerase in vitro [Abstract]. Proc. Ann. Meet. Am. Assoc. Cancer Res. (1995) 36:A2455.
   Google Scholar
• HAMILTON SE, IYER M, NORTON JC, COREY DR: Specific and nonspecific inhibition of transcription by DNA, PNA, and phosphorothioate promoter analog duplexes. Bioorg. Med. Chem. Lett. (1996) 6:2897–2900.
   Web of Science ®Google Scholar
• NORTON JC, PIATYSZEK MA, WRIGHT WE, SHAY JW, COREY DR: Inhibition of human telomerase activity by peptide nucleic acids. Nature BiotechnoL (1996) 14:615–619.
   PubMed Web of Science ®Google Scholar
• Detailed description of PNAs.
   Google Scholar
• SALAZAR M, THOMPSON BD, KERWIN SM, HURLEY LH: Thermally induced DNA-RNA hybrid to G-Quadruplextransitions: possible implications for telomere synthe-sis by telomerase. Biochemistry (1996) 35:16110–16115.
   PubMed Web of Science ®Google Scholar
• A detailed biochemical description of G-quadruplex formation.
   Google Scholar
• SALAZAR M, THOMPSON B, KERWIN SM, HURLEY L: Un-winding of telomeric hybrids is facilitated by G-quartet formation. In: 9th NCEEORTC Symposium on NewDrugs in Cancer Therapy, Lobbezoo MW (Ed.), Kluwer Academic Publishers, Amsterdam (1996).
   Google Scholar
• THOMPSON B, SALAZAR M, SUN D et al.: Telomeraseinhibition by G-quartet interactive compounds. In: 9th NCI-EORTC Symposium on New Drugs in Cancer Therapy Lobbezoo MW (Ed.), Kluwer Academic Publishers, Amster-dam (1996).
   Google Scholar
• SUN D, THOMPSON B, CATHERS BE et al.: Inhibition oftelomerase by G-quadruplex interactive compound. J. Med. Chem. (1997) 40:2113–2116.
   PubMed Web of Science ®Google Scholar
• WHEELHOUSE RT, SUN D, HURLEY LH: Non-nucleotidetelomerase inhibitors: structure based design of G-quadruplex interactive agents [Abstract]. Proc. Ann. Meet. Am. Assoc. Cancer Res. (1997) 38:A4279.
   Google Scholar
• IZBICKA E, RAYMOND E, SUN D et al.: Evaluation of thecytotoxic effects of novel telomerase inhibitors in vitro (Abstract]. Proc. Ann. Meet. Am. Assoc. Cancer Res. (1997) 38:A4277.
   Google Scholar
• FLETCHER TM, SALAZAR M, CHEN S-F: Human telomeraseinhibition by 7-deaza-2'-deoxypurine nucleoside triphosphates. Biochemistry (1996) 35:15611–15617.
   PubMed Web of Science ®Google Scholar
• MURNANE JP, SABATIER L, MARDER BA, MORGAN WF:Telomere dynamics in an immortal human cell line. EMBO J. (1994) 13:4953–4962.
   PubMed Web of Science ®Google Scholar
• BRYAN TM, ENGLEZOU A, GUPTA J, BACCHETTI S, RED-DEL RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. (1995) 14:4240–4248.
   PubMed Web of Science ®Google Scholar
• BROUSSET P, SAATI TA, CHAOUCHE N et al.: Telomeraseactivity in reactive and neoplastic tissues: infrequent detection of activity in Hodgkin's disease. Blood (1997) 89:26–31.
   PubMed Web of Science ®Google Scholar